Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Neri

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Blood|January 9, 2025
Doubling down on GPRC5D in multiple myelomaPaola Neri
Blood|June 26, 2020
Clonal hematopoiesis in myeloma: root of all maladies!Paola Neri
Blood|December 18, 2025
Outnumbered: T-cell dominance breaks BCMA-TCE resistancePaola Neri
Blood|July 13, 2019
The Pandora's box of thalidomide analogs and their substratesPaola Neri
Blood|August 1, 2024
Plasma cells' fate: it is a complex "orchestra"Paola Neri
Blood|September 22, 2018
CRISPRing the CRL4<sup>CRBN</sup> RING in multiple myelomaPaola Neri
Critical Reviews in Oncology/Hematology|June 2, 2023
Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myelomaPaola Neri, Inger Nijhof
Expert Opinion on Biological Therapy|June 21, 2013
Genomic instability in multiple myeloma: mechanisms and therapeutic implicationsPaola Neri, Nizar J Bahlis
Blood|April 22, 2017
Multiple myeloma cells sent "PAKing"!Paola Neri, Nizar J Bahlis
Current Cancer Drug Targets|June 8, 2012
Targeting of adhesion molecules as a therapeutic strategy in multiple myelomaPaola Neri, Nizar J Bahlis
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Blood|January 9, 2025
Doubling down on GPRC5D in multiple myelomaPaola Neri
Blood|June 26, 2020
Clonal hematopoiesis in myeloma: root of all maladies!Paola Neri
Blood|December 18, 2025
Outnumbered: T-cell dominance breaks BCMA-TCE resistancePaola Neri
Blood|July 13, 2019
The Pandora's box of thalidomide analogs and their substratesPaola Neri
Blood|August 1, 2024
Plasma cells' fate: it is a complex "orchestra"Paola Neri
Blood|September 22, 2018
CRISPRing the CRL4<sup>CRBN</sup> RING in multiple myelomaPaola Neri
Critical Reviews in Oncology/Hematology|June 2, 2023
Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myelomaPaola Neri, Inger Nijhof
Expert Opinion on Biological Therapy|June 21, 2013
Genomic instability in multiple myeloma: mechanisms and therapeutic implicationsPaola Neri, Nizar J Bahlis
Blood|April 22, 2017
Multiple myeloma cells sent "PAKing"!Paola Neri, Nizar J Bahlis
Current Cancer Drug Targets|June 8, 2012
Targeting of adhesion molecules as a therapeutic strategy in multiple myelomaPaola Neri, Nizar J Bahlis
Pageof 13